ARATANA THERAPEUTICS, INC. - FORM 10-K - EX-21.1 - March 14, 2017

Attached files

file filename
EX-32.2 - EX-32.2 - ARATANA THERAPEUTICS, INC.petx-20161231xex32_2.htm
EX-32.1 - EX-32.1 - ARATANA THERAPEUTICS, INC.petx-20161231xex32_1.htm
EX-31.2 - EX-31.2 - ARATANA THERAPEUTICS, INC.petx-20161231xex31_2.htm
EX-31.1 - EX-31.1 - ARATANA THERAPEUTICS, INC.petx-20161231xex31_1.htm
EX-23.1 - EX-23.1 - ARATANA THERAPEUTICS, INC.petx-20161231xex23_1.htm
EX-10.14(C) - EX-10.14(C) - ARATANA THERAPEUTICS, INC.petx-20161231xex10_14c.htm
EX-10.13(C) - EX-10.13(C) - ARATANA THERAPEUTICS, INC.petx-20161231xex10_13c.htm
EX-10.11(B) - EX-10.11(B) - ARATANA THERAPEUTICS, INC.petx-20161231xex10_11b.htm
10-K - 10-K - ARATANA THERAPEUTICS, INC.petx-20161231x10k.htm

Exhibit 21.1



Subsidiaries of Aratana Therapeutics, Inc.:

 



 

 

 

 

 

NAME

  

JURISDICTION OF ORGANIZATION

Vet Therapeutics, Inc.

  

Delaware

Aratana Therapeutics NV

  

Belgium



ARATANA THERAPEUTICS, INC. Reports